You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for aspirin; caffeine; orphenadrine citrate and what is the scope of patent protection?

Aspirin; caffeine; orphenadrine citrate is the generic ingredient in seven branded drugs marketed by Sandoz, Bausch, Stevens J, and Galt Pharms, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

Three suppliers are listed for this compound.

Summary for ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
US Patents:0
Tradenames:7
Applicants:4
NDAs:5
Finished Product Suppliers / Packagers: 3
DailyMed Link:ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE at DailyMed

US Patents and Regulatory Information for ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stevens J ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074988-001 Apr 30, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz INVAGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074817-001 Nov 27, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 074654-001 Dec 31, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch NORGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 013416-004 Oct 27, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Galt Pharms ORPHENGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-001 May 29, 1998 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch NORGESIC aspirin; caffeine; orphenadrine citrate TABLET;ORAL 013416-003 Oct 27, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Galt Pharms ORPHENGESIC FORTE aspirin; caffeine; orphenadrine citrate TABLET;ORAL 075141-002 May 29, 1998 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.